On October 23-24, 2013 the 1st International mRNA Health Conference was held in Tübingen, Germany and herald a “New Era in Modern Medicine”,  The event brought together more than 150 attendees from leading international pharmaceutical and biotechnology companies and academic institutions. This conference “laid the foundation for the new biotechnological sector of mRNA-based therapeutics.” [1]

Initiated by CureVac and the University of Tubingen in 2013, and held in the city of Tübingen “where nucleic acids were discovered over 140 years ago”, the confernce became an annual event “for everyone who is working with mRNA for medical purposes or seeking messenger RNA as a novel tool to express proteins directly in situ.” [2]

A whole session was dedicated to mRNA vaccines of which Peter Brossart from the University of Bonn gave a presentation titled “Development of RNA based vaccines” [3]

In Cambridge, Massachusetts on November 11-12, 2014 the second conference was held with gold sponsors being AstraZeneca, BioNTech, CureVac and Moderna. [3]  Moderna Therapeutics’ presenation was titled “Is mRNA like software?“.

In 2014 Lipid Nanoparticle developer Acuitus presented this poster, and DARPA presented the “Impact of mRNA on Global Health